Summary of findings table ‐ Systemic therapy vs control
Safety of systemic therapies for the treatment of AIMSS · women with early breast cancer
1 finding from 1 review
- Systemic therapies for preventing or treating aromatase inhibitor‐induced musculoskeletal symptoms in early breast… 2022 · Cochrane Headline outcomes onlyno estimate extracted4 studies · 344 participantsVery low